Le Lézard
Classified in: Health, Sports and recreation
Subjects: PDT, FVT, MAT

PURA Kicks off 2020 EVERx CBD Sports Water Marketing Campaign Announcing 4th Year at Arnold Classic


DALLAS, Jan. 15, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) kicked off its 2020 EVERx CBD Sports Water Marketing Campaign today by announcing its fourth year participating at the Arnold Schwarzenegger's Arnold Sports Festival to be held this year March 5th-8th, in Columbus, Ohio.  EVERx was introduced for the first time nearly three years ago at Arnold Sports Festival.  EVERx has since expanded its Arnold Sports Festival marketing globally participating at Arnold events not just in the United States, but in Africa and Europe as well.  EVERx has become the leading CBD infused beverage in the sports nutrition market sector.  EVERx now has distribution in Europe, Latin America and Africa in addition to within the United States.  Look for more news on the upcoming EVERx CBD Sports Water event at the Arnold Sports Festival coming soon.  The company will also soon be publishing news on additional EVERx CBD Sports Water marketing events taking place in 2020 in addition to launching a media campaign.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Contact:
Puration, Inc.
Brian Shibley
[email protected]
+1(800)861-1350

 

SOURCE Puration, Inc.


These press releases may also interest you

at 07:56
Medtronic plc , a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptivtm closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv...

at 07:55
The "KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights about KEYTRUDA for ovarian cancer in the seven major markets. A detailed...

at 07:50
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...



News published on and distributed by: